Genmab — Maj 2024
-
Darzalex er i forvejen en stor sællert for Genmab og partneren Johnson & Johnson.
I år venter Genmab, at Johnson & Johnsons salg af Darzalex løber op i 10,9-11,5 mia. dollar, og Genmab venter uændret en royaltyindtægt fra Darzalex-salget på 12,6-13,3 mia. kr.
.\˙ MarketWire
-
A New Drug Is Helping Cervical Cancer Patients Live Longer https://www.verywellhealth.com/tivdak-outcomes-for-cervical-cancer-patients-8643474
-
-
Genmab's Silver Anniversary: Reflecting on 25 Years of Breakthroughs in Antibody Therapeutics
Interviewee: Tahi Ahmadi https://clinicaledge.xtalks.com/magazine/issue2/breakthroughs-in-antibody-therapeutics
-
In "Super-Aging" Japan, the Life Sciences Market is Booming https://www.jetro.go.jp/en/invest/insights/japan-insight/lifesciences-market-booming.html
-
Teprotumumab Treats Thyroid Eye Disease Across Age https://www.medscape.com/viewarticle/teprotumumab-treats-thyroid-eye-disease-across-age-2024a1000906?form=fpf
-
Novos blødermedikamant Mim8 når et af sine endemål i dag
https://www.proinvestor.com/boards/120390
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind